Skip to main content

Quinaretic News

FDA Medwatch Alert: Aurobindo Pharma USA, Inc. Initiates Recall of Two Lots of Quinapril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, Due to the Detection of N-Nitroso Quinapril Impurity

October 24, 2022 – East Windsor, New Jersey, Aurobindo Pharma USA, Inc. has initiated a voluntary recall of two (2) lots (refer table below) of Quinapril and Hydrochlorothiazide Tablets USP 20mg / 1...

FDA Medwatch Alert: Pfizer Voluntary Nationwide Recall of Lots of Accuretic, Quinapril and Hydrochlorothiazide, and Quinapril HCl/Hydrochlorothiazide Tablets Due to N-NitrosoQuinapril Content

NEW YORK, NY., March 21,2022. Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

High Blood Pressure, Hypertension

Quinaretic patient information at Drugs.com